Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 100 /hr
Hire Dr. Farhad V.
United States
USD 100 /hr

Scientist with 15+ years of experience in preclinical cancer research

Profile Summary
Subject Matter Expertise
Research Gray Literature Search, Systematic Literature Review, Secondary Data Collection
Consulting Scientific and Technical Consulting
Product Development Formulation
Work Experience


Johns Hopkins University

January 2009 - Present

Post Doctoral Fellow

Johns Hopkins University

January 2004 - January 2009


Ph.D. (Life Sciences)

University of Bombay

January 2020 - January 2020

M.S. (Plant Physiology)

Institute of Science

January 2020 - January 2020

  • Certification details not provided.
M R Heerma van Voss, F Vesuna, G M Bol, J Afzal, S Tantravedi, Y Bergman, K Kammers, M Lehar, R Malek, M Ballew, et al.(2017). Targeting mitochondrial translation by inhibiting {DDX}3: a novel radiosensitization strategy for cancer treatment . Oncogene. 37. (1). p. 63--74. Springer Science and Business Media {LLC}
Heerma van Voss, M.R., Vesuna, F., Trumpi, K., Brilliant, J., Berlinicke, C., de Leng, W., Kranenburg, O., Offerhaus, J.G., Bürger, H., van der Wall, E., et al.(2015). Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer . Oncotarget. 6. (29). p. 28312-28326.
Xie, M., Vesuna, F., Botlagunta, M., Bol, G.M., Irving, A., Bergman, Y., Hosmane, R.S., Kato, Y., Winnard, P.T., Raman, V.(2015). NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3 . Oncotarget. 6. (30). p. 29901-29913.
Bol, G.M., Vesuna, F., Xie, M., Zeng, J., Aziz, K., Gandhi, N., Levine, A., Irving, A., Korz, D., Tantravedi, S., et al.(2015). Targeting DDX3 with a small molecule inhibitor for lung cancer therapy . EMBO Molecular Medicine. 7. (5). p. 648-669.
Vos, S., Vesuna, F., Raman, V., van Diest, P.J., van der Groep, P.(2015). miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers . Oncotarget. 6. (31). p. 32115-32137.
Gajula, R.P., Chettiar, S.T., Williams, R.D., Thiyagarajan, S., Kato, Y., Aziz, K., Wang, R., Gandhi, N., Wild, A.T., Vesuna, F., et al.(2013). The Twist box domain is required for Twist1-induced prostate cancer metastasis . Molecular Cancer Research. 11. (11). p. 1387-1400.
Cao, M.D., Döpkens, M., Krishnamachary, B., Vesuna, F., Gadiya, M.M., Lønning, P.E., Bhujwalla, Z.M., Gribbestad, I.S., Glunde, K.(2012). Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer . NMR in Biomedicine. 25. (9). p. 1033-1042.
Vesuna, F., Lisok, A., Kimble, B., Domek, J., Kato, Y., Van Der Groep, P., Artemov, D., Kowalski, J., Carraway, H., Van Diest, P., et al.(2012). Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α . Oncogene. 31. (27). p. 3223-3234.
Yusuf, D., Butland, S.L., Swanson, M.I., Bolotin, E., Ticoll, A., Cheung, W.A., Zhang, X.Y.C., Dickman, C.T.D., Fulton, D.L., Lim, J.S., et al.(2012). The Transcription Factor Encyclopedia . Genome Biology.
Botlagunta, M., Krishnamachary, B., Vesuna, F., Winnard Jr., P.T., Bol, G.M., Patel, A.H., Raman, V.(2011). Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells . PLoS ONE. 6. (3).
Kondaskar, A., Kondaskar, S., Kumar, R., Fishbein, J.C., Muvarak, N., Lapidus, R.G., Sadowska, M., Edelman, M.J., Bol, G.M., Vesuna, F., et al.(2011). Novel, broad spectrum anticancer agents containing the tricyclic 5:7:5-fused diimidazodiazepine ring system . ACS Medicinal Chemistry Letters. 2. (3). p. 252-256.
Koskimaki, J.E., Karagiannis, E.D., Rosca, E.V., Vesuna, F., Winnard Jr., P.T., Raman, V., Bhujwalla, Z.M., Popel, A.S.(2009). Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts . Neoplasia. 11. (12). p. 1285-1291.
Sullivan, N.J., Sasser, A.K., Axel, A.E., Vesuna, F., Raman, V., Ramirez, N., Oberyszyn, T.M., Hall, B.M.(2009). Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells . Oncogene. 28. (33). p. 2940-2947.
Vesuna, F., Lisok, A., Kimble, B., Raman, V.(2009). Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression . Neoplasia. 11. (12). p. 1318-1328.
Glunde, K., Shah, T., Winnard Jr., P.T., Raman, V., Takagi, T., Vesuna, F., Artemov, D., Bhujwalla, Z.M.(2008). Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1α signaling in a human prostate cancer model . Cancer Research. 68. (1). p. 172-180.
Botlagunta, M., Vesuna, F., Mironchik, Y., Raman, A., Lisok, A., Winnard Jr., P., Mukadam, S., Van Diest, P., Chen, J.H., Farabaugh, P., et al.(2008). Oncogenic role of DDX3 in breast cancer biogenesis . Oncogene. 27. (28). p. 3912-3922.
Winnard Jr., P.T., Botlagunta, M., Kluth, J.B., Mukadam, S., Krishnamachary, B., Vesuna, F., Raman, V.(2008). Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model . Cancer Gene Therapy. 15. (10). p. 645-654.
Vesuna, F., van Diest, P., Chen, J.H., Raman, V.(2008). Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer . Biochemical and Biophysical Research Communications. 367. (2). p. 235-241.
Kato, Y., Okollie, B., Raman, V., Vesuna, F., Zhao, M., Baker, S.D., Bhujwalla, Z.M., Artemov, D.(2007). Contributing factors of temozolomide resistance in MCF-7 tumor xenograft models . Cancer Biology and Therapy. 6. (6). p. 891-897.
Raman, V., Vesuna, F.(2006). Histamine: A potential therapeutic agent for breast cancer treatment? . Cancer Biology and Therapy. 5. (11). p. 1472-1473.
Vesuna, F., Winnard Jr., P., Raman, V., Glackin, C.(2006). Twist overexpression promotes chromosomal instability in the breast cancer cell line MCF-7 . Cancer Genetics and Cytogenetics. 167. (2). p. 189-191.
Duriseti, S., Winnard Jr., P.T., Mironchik, Y., Vesuna, F., Raman, A., Raman, V.(2006). HOXA5 regulates hMLH1 expression in breast cancer cells . Neoplasia. 8. (4). p. 250-258.
Vesuna, F., Winnard Jr., P., Raman, V.(2005). Enhanced green fluorescent protein as an alternative control reporter to Renilla luciferase . Analytical Biochemistry. 342. (2). p. 345-347.
Mironchik, Y., Winnard Jr., P.T., Vesuna, F., Kato, Y., Wildes, F., Pathak, A.P., Kominsky, S., Artemov, D., Bhujwalla, Z., Van Diest, P., et al.(2005). Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer . Cancer Research. 65. (23). p. 10801-10809.
Bandyopadhyay, D., Vesuna, F.D.(2002). Detection and evaluation of non-recombinants in cDNA libraries by multiple cloning region PCR . BioTechniques. 32. (1). p. 88-92.